Download presentation
Presentation is loading. Please wait.
1
Drugs and Urinary Incontinence
Cheryl Ritchie R.Ph., CGP Janzen’s Pharmacy Thunder Bay, ON
2
Medications and Urinary incontinence Presentation Outline
Bladder receptors – Drug activity sites Drugs contributing to urinary incontinence Drugs for treatment of urinary incontinence
3
Alpha Adrenergic Receptors in Bladder
Stimulation Sphincter contraction Inhibit urine flow Block receptors Sphincter relaxation Allow urine flow
4
Beta adrenergic receptors in bladder
Stimulation Detrusor muscle relaxation Allows bladder filling Block receptors Detrusor muscle contraction Facilitates bladder emptying
5
Muscarinic (M2 & M3 - Cholinergic) Receptors
Stimulation Detrusor muscle contraction Facilitates bladder emptying Block receptors Detrusor muscle relaxation Facilitates bladder filling
6
Medications contributing to Incontinence
Stress Incontinence Alpha adrenergic blocking agents cause sphincter relaxation Terazosin doxazosin ACE inhibitors may cause cough Enalapril Ramipril Lisinopril fosinopril
7
Medications contributing to Urinary Incontinence
Urge incontinence due to uncontrolled bladder contractions or increased urine output Diuretics Caffeine Sedative Hypnotics
8
Medications contributing to urinary incontinence
Urinary retention due to decreased bladder contractions Anticholinergics – oxybutynin, scopolamine Antidepressants – amitriptyline, doxepin Antipsychotics – chlorpromazine, prochlorperazine Sedative hypnotics – diazepam, flurazepam Antihistamines – diphenhydramine, hydroxyzine, chlorpheniramine Muscle relaxants – baclofen, cyclobenzaprine Calcium Channel Blockers – diltiazem,nifedipine, verapamil Antiarrhytmics - quinidine Antiparkisonian agents – trihexyphenidyl, benztropine
9
Medications Contributing to Urinary Incontinence
Urinary retention due to sphincter contraction Alpha adrenergic agonists pseudoephedrine Urinary retention due to detrusor muscle relaxation Beta adrenergic agonists Salbutamol terbutaline
10
Medications contributing to urinary incontinence
If medications are a contributing factor – consider an alternative medication If not able to discontinue offending medication, the lowest possible dose of the aggravating medication should be used.
11
Medications to treat urinary incontinence - goals of treatment
Decrease uninhibited bladder contractions Increase functional bladder capacity Decrease frequency and urgency
12
Drugs in the management of urinary incontinence – Points to consider
Will adding medication improve or complicate quality of life? Drug therapy alone rarely cures elderly urinary incontinence sufferers. Ensure accurate diagnosis prior to choosing drug therapy
13
Drugs in treatment of urinary incontinence – stress incontinence
Topical estrogens Increase sphincter tone Duloxetine – unlabelled use By blocking norepinehrine reuptake may increase sphincter control
14
Drugs in the treatment of urinary incontinence – Urge incontinence
Oxybutynin - Ditropan Tolterodine - Detrol
15
Drugs in the treatment of urinary incontinence – Urge incontinence
Adverse effects of oxybutynin & tolterodine Dry mouth Constipation Dry eyes or blurred vision Tachycardia Worsening GERD Worsening cognitive impairment (especially with cholinesterase inhibitors)
16
Drugs in the treatment of urinary incontinence – Urge incontinence
Contraindications Urinary and gastric retention Uncontrolled narrow angle glaucoma
17
Drugs in the treatment of urinary incontinence – Urge incontinence
Drug interactions Additive effects with other anticholinergic medications Tolterodine only (reduce dose) Azole antifungals Cyclosporine Macrolide antibiotics Fluoxetine – if possible choose alternative SSRI
18
Drugs in the treatment of urinary incontinence – Urge incontinence
Dosage form availability Immediate release tablet Extended release tablet Transdermal patch (oxybutynin only) Dosage form notes Short acting may be good choice for occasional use for special occasions Long-acting formulation may cause less adverse effects
19
Drugs in the treatment of urinary incontinence – overflow incontinence
UI associated with benign prostatic hyperplasia Alpha adrenergic antagonists Terazosin, doxazosin Non-selective – monitor for hypotension especially with first dose alfuzocin, tamsulosin 5-alpha reductase inhibitors Finasteride, dulasteride
20
Drugs in the management of urinary incontinence – Points to consider
Several weeks of drug therapy are usually required to achieve maximum effect If no subjective improvement in 4-6 weeks, consider Increase dose Change medication Discontinue medication
Similar presentations
